Vaniprevir ( MK-7009 ) is a hepatitis C virus ( HCV ) non-structural 3/4a protease inhibitor which significantly increases virologic response rates in HCV genotype ( GT ) 1-infected patients when added to peginterferon and ribavirin ( PR ) .